Monkeypox Virus Antigen Detection Kit (Colloidal Gold Method)

Monkeypox Virus Antigen Detection Kit (Colloidal Gold Method) is a lateral flow immunoassay for the qualitative detection of monkeypox virus antigen in human serum, plasma or whole blood samples or rash exudate. It is intended to be used as a screening test and provides a preliminary test result for early diagnosis and management of patients related to infection with Monkeypox.

Any interpretation or use of this preliminary test result must also rely on other clinical findings as well as on the professional judgment of health care providers. Alternative test method(s) should be combined to confirm the test result obtained by this device.

Monkeypox is a viral zoonotic disease with symptoms in humans similar to those seen in the past in smallpox patients. Monkeypox occurs in monkeys in the rain forests of central and western Africa, and can also infect other animals and occasionally humans. The clinical manifestations are similar to those of smallpox, but the disease is milder. The virus can be transmitted from animals to humans through direct close contact, and it can also spread from person to person. The main routes of infection include blood and body fluids. However, monkeypox is far less contagious than the smallpox virus.

Monkeypox Virus Antigen Detection Kit (Colloidal Gold) is an immunological diagnostic test used for detection of monkeypox virus Antigen based on the colloidal gold-immunochromatography assay. This method is rapid and convenient to use and requires few equipment. It can be performed within 15-20 minutes by minimally skilled personnel.